ohm, considering your last line, "A combination
Post# of 153820
Quote:
"A combination of leronlimab, Trodelvy and a PD-L1 inhibitor would take care of tumors whether hot or cold."
do you think that could be one of the reasons why CytoDyn decided to do a pre-clinical with Trodelvy? We already know how it works with Keytruda, not so much with an ADC.
What do you think the chances of a triple partnership would be such as G, Merck and CytoDyn?
What do you think of Hope Rego being on both SABs of G and CytoDyn? She has extensive experience with Trodelvy. Do you think they could be considering a threesome? What about Pestell?

